26 October 2022

AXSANA: a clinical trial to see if it is possible to avoid unnecessary axillary lymph node dissection in breast cancer patients

October is World Breast Cancer Awareness Month. Throughout this month of October we will present a series of short videos about the Breast Unit's clinical activities and its research projects.

AXSANA: a clinical trial to see if it is possible to avoid unnecessary axillary lymph node dissection in breast cancer patients

Axillary lymph node dissection is a procedure to remove all lymph nodes in the armpit so as to avoid breast cancer recurrence. But, explains David Pinto, a surgeon at the Breast Unit of the Champalimaud Foundation, it causes complications – and, in 40% of the cases, it is unnecessary. Since comparative studies on alternative procedures are scant, the Unit is also participating in the European clinical trial AXSANA, which will provide results within two years.

Loading
Please wait...